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Abstract
Dnmt2/Trdmt1 is a methyltransferase, which has been shown to methylate tRNAs. Deficient
mutants were reported to exhibit various, seemingly unrelated, defects in development and
RNA-mediated epigenetic heredity. Here we report a role in a distinct developmental regula-
tion effected by a noncoding RNA. We show that Dnmt2-deficiency in mice results in cardiac
hypertrophy. Echocardiographic measurements revealed that cardiac function is preserved
notwithstanding the increased dimensions of the organ due to cardiomyocyte enlargement.
Mechanistically, activation of the P-TEFb complex, a critical step for cardiac growth, results
from increased dissociation of the negatively regulating Rn7sk non-coding RNA component
in Dnmt2-deficient cells. Our data suggest that Dnmt2 plays an unexpected role for regula-
tion of cardiac growth by modulating activity of the P-TEFb complex.
Introduction
Dnmt2/Trdmt1 is a member of the cytosine-5 methyltransferase family and shows strong
sequence conservation to the catalytic motifs of established DNAmethyltransferases [1]. How-
ever, Dnmt2-dependent DNAmethylation has been found to be very low or absent in vivo [2],
but Dnmt2-dependent methylation of tRNAs, which protects them from cleavage, has been
reported [2, 3]. In Zebrafish, Dnmt2 knockdown experiments have been shown to induce lethal
differentiation defects in the retina, liver, and brain [4]. Phalke et al. have indicated that Dnmt2
controls transposable elements in Drosophila [5] and Drosophila mutants showed reduced via-
bility under stress conditions [3]. Furthermore, Dnmt2 plays a role in non-random sister chro-
matid segregation in adult testicular stem cells in Drosophila [6]. Recent studies in mice have
shown that RNA- mediated epigenetic heredity requires Dnmt2 [7] and that endochondral
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ossification is delayed in newborn Dnmt2-deficient mice [8]. Interestingly, Tuorto et al. per-
formed proteomic analyses in this recent study and gene ontology annotation identified cardio-
vascular disease as the most up-regulated category in Dnmt2-deficient mice [8]. However, the
function of Dnmt2 in the heart remained elusive. We report here a cardiac hypertrophy pheno-
type in Dnmt2-deficient mice, which seems to be governed by noncoding RNAs.
Studies in mouse myocardium have shown that induction of Cdk9/cyclin T1 or Cdk7/cyclin
H activity is linked to cardiac hypertrophy [9,10]. Cdk9/cyclin T1 acts as a principal mediator
of RNAPII C-terminal domain (CTD) phosphorylation. In particular, RNAPII CTD phosphor-
ylation increases mRNA and protein expression, which mediates cardiac growth [11].
Mouse B2 RNA inhibits RNA polymerase II (Pol II) CTD phosphorylation by TFIIH via
interaction with the polymerase [12,13]. In vitro studies suggested that the presence of B2 RNA
at a promoter prevents phosphorylation of Ser5 residues on the CTD by TFIIH. Sequence anal-
yses of B2 families showed that they are closely related to tRNA genes [14,15].
Rn7sk is a small nuclear RNA that inhibits Cdk9 activity through physical association with
the Cdk9/cyclin T complex [16,17]. Rn7sk does not inhibit Cdk9 directly, but bridges P-TEFb
(Positive Transcription Elongation Factor b) to Hexim1 (hexamethylene bisacetamide-induced
protein 1), which in turn inhibits Cdk9 function [18,19].
We have shown previously that transcriptional induction of Cdk9 following small non-cod-
ing RNAs (sncRNAs) injection into one-cell embryos results in cardiac hypertrophy in mice
[20]. To investigate a potential role of Dnmt2 for cardiac growth, we examined Cdk9, RNA pol
II phosphorylation, and Rn7sk in Dnmt2-deficient mice compared to wild-type littermates.
RNA pol II was highly activated in Dnmt2-deficient hearts, which most likely results from a
decreased methylation and an increased Rn7sk dissociation from P-TEFb complex. Thus, we
postulate that Dnmt2 prevents over-activation of RNA pol II and cardiac hypertrophy.
Materials and Methods
Mice and genotyping
The experiments described here were carried out in compliance with the relevant institutional
and French animal welfare laws, guidelines and policies. They have been approved by the
French ethics committee (Comité Institutionnel d’Ethique Pour l’Animal de Laboratoire; num-
ber NCE/2012-54). Dnmt2 -/- homozygote knockout mice [2] were kindly provided by T. Bes-
tor. Originally maintained on a mixed genetic background, the mutation was backcrossed for
more than ten generations onto the C57BL/6 genetic background. Genotypes were determined
by PCR analysis of Neo and LacZ expression and by Southern blot hybridization using a geno-
mic probe. Routinely, genotyping was performed by PCR yielding bands of 350 bp and 250 bp
for the wild-type and knockout allele, respectively (Fig 1A).
Cardiac experimentation procedures
Three months old male and female mice were used. Xylazine/Ketamine-anaesthetized mice
(100 mg/kg body weight for Ketamine and 10 mg/kg body weight for Xylazine injected intra-
peritoneally) were examined by echocardiography using the iE33 xMATRIX system with a
12MHz transducer (Philips Healthcare, DA Best, Netherlands). Anesthesia lowered the heart
rate compared to conscious mice without significant differences for Dnmt2-/- and Dnmt2+/+
animals. Histology and measurement of cardiomyocyte diameters was performed according to
established protocols [20,21]. Three μm paraffin sections were used for histological and immu-
nohistological procedures. Haematoxylin-Eosin staining was routinely performed on all tissue
samples; additionally, sections were stained with wheat germ agglutinin (WGA) (1:100, Life
Technologies, Molecular Probes) and Picrosirius Red. Slides were photographed using a slide
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scanner (Leica Microsystems, Nanterre, France) or an epifluorescence microscope (DMLB,
Leica, Germany) connected to a digital camera (Spot RT Slider, Diagnostic Instruments, Scot-
land). ImageJ was used to determine Picrosirius Red area densities (n = 5 animals each), as well
as cardiomyocyte diameters at the level of the nucleus in longitudinal sectioned cells of the
interventricular septum for the HE staining (n = 255 cells for Dnmt2-/- and n = 305 cells for
Dnmt2+/+, n = 5 animals each) or cardiomyocyte diameters at the level of the nucleus in trans-
versal sectioned cells of the interventricular septum for the WGA staining (n = 391 cells for
Dnmt2-/- and n = 367 cells for Dnmt2+/+, n = 5 animals each). Investigators were blinded for
the genotype of the mice.
Cell culture
Mouse embryonic fibroblasts (MEFs) prepared from 12.5 days embryos were inactivated by
10μg/ml mitomycin (Sigma). Dnmt2 knock out, kindly provided by T. Bestor, and control ES
cells were grown on inactivated feeder cells in standard ES culture medium. According to well-
established procedures [22], embryoid bodies were generated from knock out and control ES
cells by culture in hanging drops, the cells were plated back on gelatin-coated plates 3 days
later and cardiac differentiation was monitored by the appearance of beating cells.
Western blot analysis
Total lysates from cell cultures and hearts were prepared, electrophoresed, and blotted. The fol-
lowing antibodies were used for immunodetection: polyclonal anti-CDK9 antibody from rabbit
(H-169, sc-8338, Santa Cruz Biotechnology) in a 1:500 dilution in PBS, 2.5% Blotto, 0.05%
Tween-20, polyclonal anti-RNA Pol II from rabbit (N-20, Santa Cruz Biotechnology sc-899)
1:500, mouse monoclonal anti ß-actin (Santa Cruz Biotechnology), peroxidase-coupled goat
anti-rabbit secondary antibody (Santa Cruz Biotechnology) 1:10000, and peroxidase-coupled
rabbit anti-mouse secondary antibody (Santa Cruz Biotechnology) 1:10000. Western Blots
(n = 2) were quantified using ImageJ with the Gel Analysis tool.
RNA immunoprecipitation
Total RNA was prepared from hearts of Dnmt2-deficienct mice and wild-type littermates
(n = 6 each) using Trizol Reagent (Invitrogen). Ten μg total RNA were incubated with 2 μg of
5-mC monoclonal antibody (33D3, Diagenode) overnight at 4°C in 500 μl RIP buffer (150 mM
KCL, 25 mM Tris pH 7.4, 5 mM EDTA, 0.5 mM DTT, 0.5% NP40, 100 U/ml RNAse inhibitor
(Invitrogen)) complemented with protease inhibitor (Complete1, Roche Diagnostics, India-
napolis, USA). Afterwards, protein G beads (50 μl, GE Healthcare) were added and after 1
hour incubation, 3 washes of pelleted beads performed in RIP buffer. 5-mC antibody
Fig 1. Dnmt2-deficiency induces cardiac growth with preserved function. (A) Representative semiquantitative RT-PCR to genotype
Dnmt2-/- and Dnmt2+/+ animals. (B) Representative echocardiographic recordings from Dnmt2-/- and Dnmt2+/+ animals. The interventricular
septum (IVS), left ventricular internal dimensions (LVID), and leftventricular posterior wall (LVPW) are indicated. White bars represent
systolic and diastolic measuring points. The arrow represents the cursor position from the echocardiographic recording and has no
biological meaning. Lower panel: Echocardiographic examination indicates increased left ventricular mass, systolic and diastolic volumes,
but preserved ejection fraction in Dnmt2-/- (n = 8) compared to control mice (n = 6). (C) Representative photographs of the hearts. (D)
Photomicrographs of hematoxylin-eosin (HE) stained cross-sections of the hearts. Scale bars indicate 2mm. (E) Heart-to-body weight
ratios (n = 8). (F) Photomicrographs of WGA-stained sections showing transversal cross sections of individual cardiomyocytes and
quantification of cardiomyocyte diameters (n = 5 for each group). (G) High power photomicrographs of HE-stained longitudinal sections
showing individual cardiomyocytes and quantification of cardiomyocyte diameters and cellularity per field (n = 5 for each group). (H)
Representative photographs of Picrosirius Red stained heart cross sections and quantification of Picrosirius Red area densities as a
measure for collagen deposits (n = 5 for each group). Scale bars indicate 50μm. (F) Data are mean ± SEM. *p < 0.05, **p < 0.01,
***p < 0.001.
doi:10.1371/journal.pone.0156953.g001
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precipitated RNAs were isolated using Trizol Reagent. cDNA synthesis was performed using
the Maxima First strand cDNA Synthesis kit (Thermo Scientific) and quantitative PCR for
Rn7sk using SYBR Select Master Mix (Applied Biosystems). Traces of non-specific bound
GAPDH served for normalization.
Northern blot analysis
Northern blot analysis was performed as described [23]. Briefly, 6 μg total RNA extracted from
cell cultures and hearts was loaded onto a 12% denaturing polyacrylamide gel and electropho-
resed until the bromophenol blue marker reached the bottom of the gel. The separated RNA
was electrotransferred to a Hybond N+ membrane (Amersham). Hybridization was carried
out in the presence of 32 P-endlabeled DNA oligonucleotide probes. The following probe
sequence was used 5’-GAAGAGGACGACCTTCCCCG-3’.
Quantitative RT-PCR
RNA extraction and quantitative RT-PCR were performed as described [24]. Briefly, RNA was
extracted using Trizol Reagent (Invitrogen). 1μg RNA samples were reverse transcribed to
cDNA by using random primers hexamers and MLV reverse transcriptase (Invitrogen). Quan-
titative PCR was performed using the ‘Platinum1 SYBR1 Green qPCR SuperMix-UDG’ kit
(Invitrogen). miR-1 determinations were performed with the Taqman MicroRNA Assay
(Applied Biosystems) mmu-miR-1. Sequences of oligonucleotides primers are listed in Table 1.
The 2^-ddCT method was used for calculation.
Rn7sk-Cdk9 complex immunoprecipitation
Immunoprecipitation assays were performed as described [25]. ES cells were washed with PBS
twice before formaldehyde (1% in PBS) crosslinking. Afterwards, cells were again washed with
PBS twice before incubating in lysis buffer consisting of 10 mMHEPES, pH 7.0, 0.5% Nonidet
P-40, 100 mM KCl, 5 mMMgCl2, 1mM DTT, 100U/ml RNasin (Promega), 2 mM vanadate
(Sigma-Aldrich). One tablet of protease inhibitor mixture (Complete Mini1, Roche Diagnos-
tics, Indianapolis, USA) was added just prior to use. Whole cell lysates were incubated on ice
for 30 min and the protein concentration was determined using a BCA protein assay kit
(Pierce, Rockford, IL). 500 μg proteins were incubated with 10μg polyclonal anti-Cdk9 anti-
body from rabbit (H-169, sc-8338, Santa Cruz Biotechnology) for 4h. Alternatively, 10 μg of a
Table 1. Primers for quantitative RT-PCR analysis.
Gene Accession number Primer symbol Sequence 5’-3’
Cdk9 NT-033778 Cdk9-F TAAAGCCAAGCACCGTCAG
Cdk9-R GATTTCCCTCAAGGCTGTGAT
myh6 NC_000080.5 myh6-F CCAAGACTGTCCGGAATGA
myh6-R TCCAAAGTGGATCCTGATGA
myh7 NC_000014.8 myh7-F GGCCTCCATTGATGACTCTG
myh7-R CGCCTGTCAGCTTGTAAATG
Gapdh NM_008084 Gapdh-F TGTCCGTCGTGGATCTGAC
Gapdh-R CCTGCTTCACCACCTTCTTG
Rn7sk NC_000075.6 Rn7sk-F AGGACGACCTTCCCCGAATA
Rn7sk-B GCGCCTCATTTGGATGTGTC
Ctip2 NC_000078.6 Ctip2-F TACTGTCACCCACGAAAGGC
Ctip2-B TGGGAAGAGGAGGCAGCTAT
doi:10.1371/journal.pone.0156953.t001
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polyclonal anti-Cyp2 antibody from rabbit (H-21, sc-133491, Santa Cruz Biotechnology) were
used as a negative control. Protein A–agarose beads were added and rotated at 4°C for 4h.
RNA protein complexes were washed 4 times with polysome lysis buffer (100mM KCl, 5mM
MgCl2, 10mMHEPES, 0.5% Nonidet P-40, 1mM DTT, 100U/ml RNasin RNase inhibitor
(Promega), 2mM vanadyl ribonucleoside complexes solution (Sigma-Aldrich), 25μl protease
inhibitor cocktail (pH 7.0). RNA protein complexes were eluted from beads with polysome
lysis buffer including 0.1% SDS and 30μg proteinase K and reverse cross-linked at 50°C for 30
min, followed by TRIzol (Invitrogen) extraction and ethanol precipitation.
Statistical Analysis
Data are expressed as means ± SEM. ANOVA with the Bonferroni test as post hoc test was
used versus controls. Differences between two groups were tested using the Mann-Whitney
test for nonparametric samples. Differentiation of 200 wild-type and Dnmt2-deficient ES cell
clones each was estimated for each time point using a contingency table with Fisher’s test and
Yate’s correction. A p-value less than 0.05 is considered statistically significant.
Results
Cardiac hypertrophy in Dnmt2-deficient mice
Echocardiographic examination of adult Dnmt2-/- mice compared to age-matched controls
revealed increased left ventricular mass relative to body weight and higher left ventricular
end-diastolic and end-systolic volumes whereas the ejection fraction as measure of cardiac con-
tractility was preserved (Fig 1B). Dnmt2-deficient mice showed macroscopically and micro-
scopically increased hearts sizes compared to controls (Fig 1C and 1D). Heart weights relative
to body weights were increased on average by 20% (Fig 1E). Body weights were comparable
(data not shown). Measurements of cardiomyocyte diameters revealed an increase by approxi-
mately 20% in Dnmt2-/- mice compared to wild-type littermates, whereas the cellularity
remained unchanged (Fig 1F and 1G). Dnmt2-/- hearts displayed more fibrosis than the wild-
type counterparts (Fig 1H).
Activation of RNA pol II in Dnmt2-deficient cells
To monitor RNA pol II phosphorylation in the heart, we performedWestern blotting with an
antibody that recognizes both, hyperphosphorylated and hypophosphorylated pol II (IIo and
IIa, respectively). Interestingly the proportion of phosphorylated versus total pol II, the form
required for productive transcript elongation, increased in Dnmt2-deficient mice (Fig 2A).
Similarly, more active form of RNA polymerase II was detectable in Dnmt2-deficient ES cells
compared to wild-type cells (Fig 2B).
Enhanced cardiac differentiation of Dnmt2 knock-out ES cells
The morphology and growth characteristics of Dnmt2-deficient ES cells were comparable to
wild-type ES cells; and they did not exhibit any sign of differentiation, neither into cardiac
muscle nor otherwise. As it is established that activated RNA pol II plays a key role in cardiac
growth and differentiation and we could detect more active form of RNA polymerase II in
Dnmt2-deficient ES cells, we tested the differentiation potency of Dnmt-deficient ES cells in
vitro. Culture of the Dnmt2-deficient and control ES cells in hanging drops led to their aggre-
gation in embryoid bodies (EB) [22]. After plating the cells back on gelatin-coated plates 2 days
later, cardiac differentiation, monitored by the appearance of beating cells, progressed at a
faster rate in Dnmt2-deficient cells compare to wild-type ES cells (Fig 3A). While the fraction
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PLOS ONE | DOI:10.1371/journal.pone.0156953 June 6, 2016 6 / 13
of beating wild-type EBs was about 50%, it was almost 100% for Dnmt2 Dnmt2-deficient EBs
on day 6 of differentiation. Accordingly, quantitative RT-PCR determination of cardiac marker
genes showed higher values in Dnmt2-deficient EBs than in wild-type EBs. Myh6, Myh7, and
miR-1, which were undetectable in undifferentiated Dnmt2-deficient and wild-type ES cells
(data not shown), were found, as expected [26], to be increased along with differentiation (Fig
3B and 3D). Significant up-regulation of Myh6 and Myh7 could also be detected in the hearts
of Dnmt2-deficient animals as compared to their wild-type littermates (Fig 3C) whereas miR-1
expression was only slightly increased (Fig 3E).
The P-TEFb complex is activated in Dnmt2 knock-out cells
We thought that activation or over-expression of the P-TEFb complex may have a role in the
observed phenotype in growth and differentiation of cardiac cells in vivo and in vitro. Cdk9
positively and Rn7sk negatively regulates the P-TEFb complex, CTIP2 represses the Cdk9
kinase activity of P-TEFb [27]. Cdk9 expression did not differ significantly in Dnmt2- deficient
and wild-type ES cells and mouse hearts, neither on the RNA nor on the protein level. (Fig 4A
and 4B). Expression of Ctip2 was unchanged in Dnmt2- deficient as compared to wild-type
hearts (Fig 4C). Northern blot and RT-PCR assays done with RNA extracted from hearts
showed no change in the expression of Rn7sk in Dnmt2-deficient mice compared to controls
Fig 2. Dnmt2-deficiency is associated with increased phosphorylation of RNA polymerase II.
Representative Western Blots for RNA polymerase II (RNA Pol II, upper panels) and quantification of the ratio
of phosphorylated to non-phosphorylated RNA Pol II (lower panels) in mouse hearts (A) and ES cells (B) with
knockout of Dnmt2 and controls. β-actin was used as a standard. Data are mean ± SEM. *p < 0.05.
doi:10.1371/journal.pone.0156953.g002
Dnmt2 Regulates RNA Pol II in Cardiac Growth
PLOS ONE | DOI:10.1371/journal.pone.0156953 June 6, 2016 7 / 13
Fig 3. Dnmt2-deficiency enhances cardiac differentiation in ES cells in vitro. (A) Embryoid bodies of
hanging drop cultures from Dnmt2+/+ and Dnmt2-/- ES cells were seated individually (n = 200 each) in 48-well
tissue culture plates and the appearance of beating cells monitored daily. (B) RNA was extracted at different
Dnmt2 Regulates RNA Pol II in Cardiac Growth
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(Fig 4D and 4E). It has been shown previously that Rn7sk dissociation from the P-TEFb com-
plex is one of the most important P-TEFb activating factors [9–11]. Based on our results we
hypothesized that methylation and association of Rn7sk to the P-TEFb complex might have
changed in Dnmt2- deficient cells. To test this hypothesis, RNA immunoprecipitation using a
5-methyl Cytidine antibody with RNA extracted from hearts was performed, followed by
RT-PCR with specific primers to amplify Rn7sk. The results demonstrate that Rn7sk is signifi-
cantly less methylated in Dnmt2-deficient cardiac cells (Fig 4F). Additionally, a PTEF-b immu-
noprecipitation assay was done on lysates from Dnmt2-deficient and wild-type ES cells using
an antibody against Cdk9. Immunoprecipitation with an antibody against Cyp2 served as nega-
tive control. RNA co-immunoprecipitated by Cdk9 and Cyp2 antibodies was thereafter ana-
lyzed by RT-PCR using specific primers to amplify Rn7sk, indicating less enrichment of Rn7sk
in Dnmt2-deficient compared to wild-type samples. No enrichment was observed using the
Cyp2 antibody indicating specificity for the P-TEFb complex (Fig 4G). A scheme illustrating
our findings and hypotheses of Dnmt2-mediated RNA polymerase II transcriptional activity in
cardiac growth is provided in Fig 5.
Discussion
It has been shown that Dnmt2 is part of the RNA processing machinery during cellular stress,
by which Dnmt2-mediated tRNA methylation protects tRNA from endonucleolytic cleavage
[3]. In vitromethylation studies failed to show other substrates for Dnmt2 other than tRNA,
which was achieved by incubation of Dnmt2 protein with purified total RNA [2]. It is impor-
tant to note that these in vitro reconstitution studies rely on purified protein components and a
controlled environment may not accurately reflect the complex intracellular atmosphere.
Besides these in vitro studies, and the recent report on the role of Dnmt2 for bone formation in
mice [8], little is known about Dnmt2 function in mammals. In the present study, we report a
cardiac hypertrophy phenotype in Dnmt2- deficient mice, which seems to be mediated via acti-
vation of the P-TEFb complex.
We have previously shown that small non-coding RNAs can induce hereditary epigenetic
variations and act as the transgenerational signalling molecules [20, 28, 29]. To consider a role
of the Dnmt2 methyltransferase in RNAmediated epigenetic inheritance, we investigated the
transgenerational inheritance of previously established phenotypes in Dnmt2 deficient mice
[7]. In Kit and Sox9 paramutant models, the epigenetic variants of the respected locus were
prevented in Dnmt2- deficient mice [7]. Cdk9 paramutant animals displayed a hereditary car-
diac hypertrophy [20]. Thus, we investigated whether Dnmt2 might also be involved in cardiac
growth. Interestingly, we describe here a cardiac hypertrophy phenotype in Dnmt2-deficient
mice independent from Cdk9 locus induction, mediated by the non-coding RNA Rn7sk.
Activation of RNA pol II, a key player in cardiac hypertrophy, was identified not only in
Dnmt2- deficient mice, but also in Dnmt2-deficient ES cells. Apart from proteins such as
Cdk9, non-coding RNAs including Rn7sk and B2 RNAs tightly regulate RNA pol II activation.
We focused on the identification of possible functions of non-coding RNAs in the observed
cardiac hypertrophy in Dnmt2- deficient animals. Rn7sk methylation in an NSun2-dependent
manner has been already demonstrated [30]. Thus, we focussed on potential methylation of
timepoints of differentiation from additional Dnmt2-deficient and control ES cell clones (n = 6 each) and
quantitative RT-PCR analysis of cardiac differentiation markers Myh6, and Myh7 was performed. (C)
Quantitative RT-PCR for Myh6, and Myh7 in Dnmt2-/- and Dnmt2+/+ hearts (n = 6 for each group). (D)
Quantitative RT-PCR for miR1 at different timepoints of differentiation from Dnmt2-deficient and control ES
cell clones (n = 6 each). (E) qRT-PCR for miR1 in Dnmt2-/- and Dnmt2+/+ hearts (n = 6 for each group).
*p < 0.05, **p < 0.01, ***p < 0.001.
doi:10.1371/journal.pone.0156953.g003
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Rn7sk by the other known RNAmethyltransferase Dnmt2. Initial bisulfite sequencing was not
sensitive enough in our hands to detect robust methylation differences for Rn7sk (data not
shown). By RNA immunoprecipitation using a 5-methyl Cytidine antibody followed by
Fig 4. Dnmt2-deficiency affects the P-TEFb complex. (A) Cdk9 expression in Dnmt2-deficient and control ES cells was analyzed
by quantitative RT-PCR (left) and Western blot assays (right). (B) Cdk9 expression in Dnmt2-deficient and control hearts was
investigated by quantitative RT-PCR (left) (n = 5) andWestern blot assays (right). (C) Quantitative RT-PCR for Ctip expression in
the hearts of Dnmt2-/- and Dnmt2+/+ mice (n = 6). Northern blot assay (D) and quantitative RT-PCR (E) for Rn7sk (7SK) expression
in the hearts of Dnmt2-/- and Dnmt2+/+ mice. (F) RNA immunoprecipitation using a 5-methyl Cytidine antibody with RNA extracted
from Dnmt2-/- and Dnmt2+/+ hearts, followed by RT-PCR for Rn7sk (n = 6). Note that Rn7sk is significantly less methylated in
Dnmt2-/- hearts. (G) PTEF-b immunoprecipitation using an antibody against Cdk9 on lysates from Dnmt2- mutant and control ES
cells followed by RT-PCR for Rn7sk (n = 3) and subsequent quantification. An anti Cyp2 antibody served as negative control. Note
that less Rn7sk is associated to the P-TEFb complex in Dnmt2-deficient cells.
doi:10.1371/journal.pone.0156953.g004
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quantitative RT-PCR we demonstrate that Rn7sk is significantly less methylated in the Dnmt2-/-
than in Dnmt2+/+ hearts. This might explain the lack of inhibition of the P-TEFb complex, as
RNAmethylation protects them from cleavage [2, 3]; and unmethylated Rn7sk might be less sta-
ble and more easily degraded. Furthermore, immunoprecipitation assays identified increased
Rn7sk dissociation from the P-TEFb complex, which was shown to be important for RNA pol II
activation and cardiac hypertrophy [11]. Whether the increased Myh6 andMyh7 expression in
vitro and in vivo results from increased occupancy of the promoters of these genes by the P-TEFb
complex or is simply reflecting cardiac hypertrophy remains an open question.
Although we cannot exclude that other yet unidentified mechanisms might contribute to
the observed phenotype, the ablation of the Dnmt2 gene is changing the levels of several genes
involved in cardiac hypertrophy in vitro and in vivo. Taken together, we suggest that Dnmt2 is
required to limit cardiac growth and differentiation by regulating RNA pol II phosphorylation,
which involves the non-coding RNA Rn7sk.
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